应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
APLT Applied Therapeutics Inc.
交易中 11-22 15:35:35 EST
9.50
+0.23
+2.48%
最高
9.60
最低
8.95
成交量
131.68万
今开
9.44
昨收
9.27
日振幅
7.01%
总市值
11.05亿
流通市值
8.03亿
总股本
1.16亿
成交额
1,227万
换手率
1.56%
流通股本
8,449万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Applied Therapeutics, Inc.2024财年第三财季实现净利润-68.59百万美元,同比减少61.88%
市场透视 · 11-16
Applied Therapeutics, Inc.2024财年第三财季实现净利润-68.59百万美元,同比减少61.88%
Applied Therapeutics, Inc.盘中异动 股价大跌5.25%
市场透视 · 11-14
Applied Therapeutics, Inc.盘中异动 股价大跌5.25%
Applied Therapeutics, Inc.盘中异动 早盘股价大跌5.27%
市场透视 · 11-12
Applied Therapeutics, Inc.盘中异动 早盘股价大跌5.27%
异动解读 | 生物技术公司Applied Therapeutics股价大涨5%
异动解读 · 11-11
异动解读 | 生物技术公司Applied Therapeutics股价大涨5%
Applied Therapeutics, Inc.盘中异动 股价大涨5.05%
市场透视 · 11-11
Applied Therapeutics, Inc.盘中异动 股价大涨5.05%
应用治疗公司(Applied Therapeutics Inc)公布截至 9 月 30 日的季度业绩 - 收益摘要
路透中文 · 11-08
应用治疗公司(Applied Therapeutics Inc)公布截至 9 月 30 日的季度业绩 - 收益摘要
Applied Therapeutics, Inc.盘中异动 早盘股价大跌5.43%
市场透视 · 10-31
Applied Therapeutics, Inc.盘中异动 早盘股价大跌5.43%
Applied Therapeutics, Inc.盘中异动 急速上涨5.26%
市场透视 · 10-30
Applied Therapeutics, Inc.盘中异动 急速上涨5.26%
Applied Therapeutics, Inc.盘中异动 股价大跌5.16%
市场透视 · 10-26
Applied Therapeutics, Inc.盘中异动 股价大跌5.16%
Applied Therapeutics, Inc.盘中异动 下午盘快速上涨5.36%报8.64美元
市场透视 · 10-12
Applied Therapeutics, Inc.盘中异动 下午盘快速上涨5.36%报8.64美元
Applied Therapeutics, Inc.盘中异动 股价大涨5.58%报8.13美元
市场透视 · 10-08
Applied Therapeutics, Inc.盘中异动 股价大涨5.58%报8.13美元
Applied Therapeutics, Inc.盘中异动 快速跳水5.06%
市场透视 · 10-03
Applied Therapeutics, Inc.盘中异动 快速跳水5.06%
Applied Therapeutics, Inc.盘中异动 下午盘股价大涨5.16%
市场透视 · 09-25
Applied Therapeutics, Inc.盘中异动 下午盘股价大涨5.16%
Applied Therapeutics, Inc.盘中异动 急速拉升5.32%报8.11美元
市场透视 · 09-23
Applied Therapeutics, Inc.盘中异动 急速拉升5.32%报8.11美元
异动解读 | Applied Therapeutics Inc. 股价大涨8.92% 受公司基本面良好及行业前景利好驱动
异动解读 · 09-19
异动解读 | Applied Therapeutics Inc. 股价大涨8.92% 受公司基本面良好及行业前景利好驱动
Applied Therapeutics, Inc.盘中异动 股价大涨5.22%
市场透视 · 09-19
Applied Therapeutics, Inc.盘中异动 股价大涨5.22%
异动解读 | APLT股价大涨80.43% 新药govorestat审批预期利好
异动解读 · 09-19
异动解读 | APLT股价大涨80.43% 新药govorestat审批预期利好
异动解读 | 应用治疗公司股价大涨逾50% FDA利好推动遗传疾病新药govorestat获批预期
异动解读 · 09-18
异动解读 | 应用治疗公司股价大涨逾50% FDA利好推动遗传疾病新药govorestat获批预期
异动解读 | FDA取消专家会议引发APLT大涨
异动解读 · 09-18
异动解读 | FDA取消专家会议引发APLT大涨
BUZZ-美国 FDA 取消遗传性疾病药物专家小组会议,Applied Therapeutics 公司股价上涨
Reuters · 09-18
BUZZ-美国 FDA 取消遗传性疾病药物专家小组会议,Applied Therapeutics 公司股价上涨
加载更多
公司概况
公司名称:
Applied Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Applied Therapeutics, Inc.于2016年1月20日在特拉华州注册成立,总部位于纽约。该公司是一家临床阶段的生物制药公司,开发了一系列新产品候选产品,针对未满足医疗需求的有效分子靶标。该公司的药物开发方法利用最近的技术进步来设计改良药物,利用生物标志物的早期使用来确认生物活性,并侧重于缩短的调节途径。他们的第一个分子靶标是醛糖还原酶,或AR,一种在氧化应激条件下将葡萄糖转化为山梨糖醇的酶,并且涉及多种疾病。他们的AR抑制剂或ARI计划目前包括三个小分子,这些小分子都被设计成有效的选择性ARI,并被设计成具有独特的组织渗透性特征,以针对不同的疾病状态,包括糖尿病并发症,心脏病和罕见的儿科代谢疾病。他们的ARI计划应用策略,他们还开发了一个针对选择性抑制磷脂酰肌醇3-激酶或PI3K亚基的程序,该子单元已导致早期肿瘤学治疗。
发行价格:
--
{"stockData":{"symbol":"APLT","market":"US","secType":"STK","nameCN":"Applied Therapeutics Inc.","latestPrice":9.5,"timestamp":1732307732867,"preClose":9.27,"halted":0,"volume":1316783,"delay":0,"floatShares":84488448,"shares":116356474,"eps":-1.429271,"marketStatus":"交易中","marketStatusCode":2,"change":0.23,"latestTime":"11-22 15:35:35 EST","open":9.44,"high":9.6,"low":8.95,"amount":12269128.236065999,"amplitude":0.070119,"askPrice":9.51,"askSize":500,"bidPrice":9.5,"bidSize":123,"shortable":3,"etf":0,"ttmEps":-1.429271,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1557806400000,"adjPreClose":9.27,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":9.768,"preClose":9.27,"latestTime":"09:04 EST","volume":200,"amount":1953.6000000000001,"timestamp":1732284291108},"postHourTrading":{"tag":"盘后","latestPrice":9.27,"preClose":9.27,"latestTime":"16:48 EST","volume":6806,"amount":63091.66,"timestamp":1732225685890},"volumeRatio":0.957971,"optionData":{"bulkOrders":[{"symbol":"APLT","call":true,"expireDate":1734670800000,"strike":"12.5","timestamp":1732289474689,"price":0.8999999761581421,"volume":4500,"amount":405000,"type":"-"},{"symbol":"APLT","call":true,"expireDate":1734670800000,"strike":"10.0","timestamp":1732289474689,"price":1.75,"volume":3000,"amount":525000,"type":"+"}]},"impliedVol":2.5584,"impliedVolPercentile":0.8611},"requestUrl":"/m/hq/s/APLT","defaultTab":"news","newsList":[{"id":"2483306159","title":"Applied Therapeutics, Inc.2024财年第三财季实现净利润-68.59百万美元,同比减少61.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306159?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686435,"startTime":"0","endTime":"0","summary":"11月16日,Applied Therapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为-68.59百万美元,同比减少61.88%;其中营业收入为122000.00美元,每股基本收益为-0.48美元。从资产负债表来看,Applied Therapeutics, Inc.总负债1.01亿美元,其中短期债务264000.00美元,资产负债比为1.06,流动比率为0.02。机构评级:截至2024年11月16日,当前有4家机构对Applied Therapeutics, Inc.目标价做出预测,其中目标均价为12.75美元,其中最低目标价为11.00美元,最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000318a23b89df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000318a23b89df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APLT"],"gpt_icon":0},{"id":"2483839545","title":"Applied Therapeutics, Inc.盘中异动 股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483839545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483839545?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:26","pubTimestamp":1731515182,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时26分,Applied Therapeutics, Inc.股票出现波动,股价快速下挫5.25%。Applied Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.07%。Applied Therapeutics, Inc.公司简介:Applied Therapeutics Inc 是一家临床阶段的生物制药公司,针对高度未满足的医疗需求,开发一系列针对经过验证的分子靶点的新型候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114002623a23498d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114002623a23498d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LU0889565916.HKD","LU0109394709.USD","APLT","LU0320765992.SGD","BK4139"],"gpt_icon":0},{"id":"2482899130","title":"Applied Therapeutics, Inc.盘中异动 早盘股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482899130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482899130?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:45","pubTimestamp":1731422722,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时45分,Applied Therapeutics, Inc.股票出现异动,股价快速下跌5.27%。Applied Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。Applied Therapeutics, Inc.公司简介:Applied Therapeutics Inc 是一家临床阶段的生物制药公司,针对高度未满足的医疗需求,开发一系列针对经过验证的分子靶点的新型候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222452298e42167&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222452298e42167&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","LENZ","APLT","BK4139"],"gpt_icon":0},{"id":"1199209158","title":"异动解读 | 生物技术公司Applied Therapeutics股价大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199209158","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199209158?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:45","pubTimestamp":1731336312,"startTime":"0","endTime":"0","summary":"2024年11月11日盘中,生物技术公司Applied Therapeutics, Inc.股价出现大幅上涨,当日涨幅达到5.15%。虽然公司并未发布任何重大利好消息,但一些因素可能推动了股价的上涨。其次,机构评级方面,所有参与评级的6家券商均给予该股买入评级,显示出对公司前景的乐观预期。此外,Applied Therapeutics所在的生物技术行业当日整体表现向好,个股活跃度和涨幅均较高。该公司的主要业务是开发针对罕见代谢疾病的新型候选药物,市场前景广阔。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 生物技术公司Applied Therapeutics股价大涨5%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["APLT"],"gpt_icon":0},{"id":"2482738815","title":"Applied Therapeutics, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738815?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:35","pubTimestamp":1731335722,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时35分,Applied Therapeutics, Inc.股票出现异动,股价大幅上涨5.05%。Applied Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。Applied Therapeutics, Inc.公司简介:Applied Therapeutics Inc 是一家临床阶段的生物制药公司,针对高度未满足的医疗需求,开发一系列针对经过验证的分子靶点的新型候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223523971a5b1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223523971a5b1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLT","LU0320765992.SGD","LU0109394709.USD","LENZ","BK4139","LU0889565916.HKD"],"gpt_icon":0},{"id":"2481362511","title":"应用治疗公司(Applied Therapeutics Inc)公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481362511","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481362511?lang=zh_cn&edition=full","pubTime":"2024-11-08 01:21","pubTimestamp":1731000116,"startTime":"0","endTime":"0","summary":"应用治疗公司公布截至 9 月 30 日的季度业绩 - 收益摘要Applied Therapeutics Inc APLT.OQ报告,截至9月30日的季度调整后每股亏损48美分,低于去年同期的每股-47美分。五位分析师对该季度的平均预期是每股亏损 16 美分。Applied Therapeutics Inc 公布的本季度每股收益为亏损 48 美分。本季度,Applied Therapeutics Inc 的股价上涨了 13.5%,今年迄今已上涨了 188.1%。华尔街对 Applied Therapeutics Inc 的 12 个月目标价中位数为 13.00 美元。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4S3ME2GQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0320765992.SGD","LU0109394709.USD","APLT","LU0889565916.HKD"],"gpt_icon":0},{"id":"2479080905","title":"Applied Therapeutics, Inc.盘中异动 早盘股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479080905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479080905?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:32","pubTimestamp":1730381557,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时32分,Applied Therapeutics, Inc.股票出现波动,股价急速下挫5.43%。Applied Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.85%。Applied Therapeutics, Inc.公司简介:Applied Therapeutics Inc 是一家临床阶段的生物制药公司,针对高度未满足的医疗需求,开发一系列针对经过验证的分子靶点的新型候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213237971a385d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213237971a385d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","APLT","LU0109394709.USD","LENZ","BK4139","LU0889565916.HKD"],"gpt_icon":0},{"id":"2479978977","title":"Applied Therapeutics, Inc.盘中异动 急速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479978977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479978977?lang=zh_cn&edition=full","pubTime":"2024-10-30 22:07","pubTimestamp":1730297278,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日22时07分,Applied Therapeutics, Inc.股票出现异动,股价大幅拉升5.26%。Applied Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.14%。其相关个股中,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.涨幅较大,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm Plc较为活跃,换手率分别为3453.48%、699.84%、56.63%,振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.,振幅分别为70.94%、52.36%、47.63%。Applied Therapeutics, Inc.公司简介:Applied Therapeutics Inc 是一家临床阶段的生物制药公司,针对高度未满足的医疗需求,开发一系列针对经过验证的分子靶点的新型候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030220759971a3405&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030220759971a3405&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APLT","LU0320765992.SGD","LENZ","LU0889565916.HKD","LU0109394709.USD"],"gpt_icon":0},{"id":"2478968121","title":"Applied Therapeutics, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478968121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478968121?lang=zh_cn&edition=full","pubTime":"2024-10-26 02:56","pubTimestamp":1729882578,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日02时56分,Applied Therapeutics, Inc.股票出现异动,股价急速下挫5.16%。Applied Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.56%。Applied Therapeutics, Inc.公司简介:Applied Therapeutics Inc 是一家临床阶段的生物制药公司,针对高度未满足的医疗需求,开发一系列针对经过验证的分子靶点的新型候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102602561898e3e8fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102602561898e3e8fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","BK4139","LENZ","LU0109394709.USD","APLT"],"gpt_icon":0},{"id":"2474804357","title":"Applied Therapeutics, Inc.盘中异动 下午盘快速上涨5.36%报8.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474804357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474804357?lang=zh_cn&edition=full","pubTime":"2024-10-12 02:02","pubTimestamp":1728669746,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日02时02分,Applied Therapeutics, Inc.股票出现波动,股价大幅上涨5.36%。截至发稿,该股报8.64美元/股,成交量65.9376万股,换手率0.57%,振幅6.95%。Applied Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.10%。Applied Therapeutics, Inc.公司简介:Applied Therapeutics Inc 是一家临床阶段的生物制药公司,针对高度未满足的医疗需求,开发一系列针对经过验证的分子靶点的新型候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101202022698e3bf06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101202022698e3bf06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","BK4139","APLT","LENZ"],"gpt_icon":0},{"id":"2473253473","title":"Applied Therapeutics, Inc.盘中异动 股价大涨5.58%报8.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473253473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473253473?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:42","pubTimestamp":1728394937,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日21时42分,Applied Therapeutics, Inc.股票出现异动,股价大幅上涨5.58%。截至发稿,该股报8.13美元/股,成交量15.4171万股,换手率0.13%,振幅4.74%。Applied Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。Applied Therapeutics, Inc.公司简介:Applied Therapeutics Inc 是一家临床阶段的生物制药公司,针对高度未满足的医疗需求,开发一系列针对经过验证的分子靶点的新型候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082142189719ef80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082142189719ef80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0889565916.HKD","APLT","LU0320765992.SGD","LU0109394709.USD","LENZ"],"gpt_icon":0},{"id":"2472617476","title":"Applied Therapeutics, Inc.盘中异动 快速跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472617476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472617476?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:45","pubTimestamp":1727966703,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时45分,Applied Therapeutics, Inc.股票出现异动,股价快速下跌5.06%。Applied Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.95%。Applied Therapeutics, Inc.公司简介:Applied Therapeutics Inc 是一家临床阶段的生物制药公司,针对高度未满足的医疗需求,开发一系列针对经过验证的分子靶点的新型候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100322450398e3a6fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100322450398e3a6fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","APLT","LU0320765992.SGD","LENZ","BK4139","LU0889565916.HKD"],"gpt_icon":0},{"id":"2470443936","title":"Applied Therapeutics, Inc.盘中异动 下午盘股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470443936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470443936?lang=zh_cn&edition=full","pubTime":"2024-09-25 02:42","pubTimestamp":1727203379,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日02时42分,Applied Therapeutics, Inc.股票出现波动,股价急速上涨5.16%。Applied Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.33%。Applied Therapeutics, Inc.公司简介:Applied Therapeutics Inc 是一家临床阶段的生物制药公司,针对高度未满足的医疗需求,开发一系列针对经过验证的分子靶点的新型候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092502425998e38b5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092502425998e38b5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LU0109394709.USD","BK4139","LU0889565916.HKD","APLT","LU0320765992.SGD"],"gpt_icon":1},{"id":"2469011101","title":"Applied Therapeutics, Inc.盘中异动 急速拉升5.32%报8.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469011101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469011101?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:33","pubTimestamp":1727098398,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时33分,Applied Therapeutics, Inc.股票出现波动,股价快速上涨5.32%。Applied Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.58%。Applied Therapeutics, Inc.公司简介:Applied Therapeutics Inc 是一家临床阶段的生物制药公司,针对高度未满足的医疗需求,开发一系列针对经过验证的分子靶点的新型候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232133199719c321&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232133199719c321&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLT","LU0109394709.USD","BK4139","LU0889565916.HKD","LU0320765992.SGD","LENZ"],"gpt_icon":1},{"id":"1115185478","title":"异动解读 | Applied Therapeutics Inc. 股价大涨8.92% 受公司基本面良好及行业前景利好驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=1115185478","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115185478?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:16","pubTimestamp":1726755389,"startTime":"0","endTime":"0","summary":"北京时间9月19日,Applied Therapeutics Inc. 股价盘中大涨8.92%,股价攀升至8.26美元。这一上涨主要得益于该公司良好的基本面以及生物制药行业整体向好带来的利好。Applied Therapeutics Inc.是一家临床阶段生物制药公司,专注于开发治疗罕见代谢疾病等新药。另外,公司所处的生物技术行业整体上涨1.28%,反映出资金或情绪面对医药板块的投资偏好,这也为Applied Therapeutics Inc.的涨势提供了助力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["APLT"],"gpt_icon":0},{"id":"2468089165","title":"Applied Therapeutics, Inc.盘中异动 股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468089165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468089165?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:51","pubTimestamp":1726753890,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时51分,Applied Therapeutics, Inc.股票出现波动,股价快速拉升5.22%。Applied Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.28%。Applied Therapeutics, Inc.公司简介:Applied Therapeutics Inc 是一家临床阶段的生物制药公司,针对高度未满足的医疗需求,开发一系列针对经过验证的分子靶点的新型候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919215131ab64a360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919215131ab64a360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLT","LU0109394709.USD","BK4139","LU0889565916.HKD","LU0320765992.SGD","LENZ"],"gpt_icon":1},{"id":"1165636313","title":"异动解读 | APLT股价大涨80.43% 新药govorestat审批预期利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1165636313","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165636313?lang=zh_cn&edition=full","pubTime":"2024-09-19 05:44","pubTimestamp":1726695867,"startTime":"0","endTime":"0","summary":"据APLT公司公告,FDA不再计划召开原定于10月9日举行的govorestat药品专家咨询委员会会议。FDA对govorestat的审批决定日期定于11月28日。药品咨询委员会会议的取消,意味着govorestat有望成为治疗罕见遗传性代谢疾病半乳糖血症的首款新药。一旦获批上市,govorestat预计将成为APLT公司的主要收益来源。这极大激发了投资者对APLT公司前景的信心,推动公司股价大涨逾80%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["APLT"],"gpt_icon":0},{"id":"1135859380","title":"异动解读 | 应用治疗公司股价大涨逾50% FDA利好推动遗传疾病新药govorestat获批预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1135859380","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135859380?lang=zh_cn&edition=full","pubTime":"2024-09-18 21:34","pubTimestamp":1726666464,"startTime":"0","endTime":"0","summary":"FDA对govorestat的审批决定日期定于11月28日。药品咨询委员会会议的取消,被市场解读为govorestat有望成为治疗罕见遗传性代谢疾病半乳糖血症的首款新药。一旦获批上市,govorestat预计将成为APLT公司的主要收益来源。这极大激发了投资者对APLT公司前景的信心,推动公司股价大涨逾50%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["APLT"],"gpt_icon":0},{"id":"1125086839","title":"异动解读 | FDA取消专家会议引发APLT大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1125086839","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125086839?lang=zh_cn&edition=full","pubTime":"2024-09-18 20:18","pubTimestamp":1726661904,"startTime":"0","endTime":"0","summary":"应用治疗公司(Applied Therapeutics Inc.,股票代码APLT)今日盘前大涨43.01%,主要原因是该公司的遗传性疾病药物govorestat获得了FDA的利好消息。\n\n根据该公司的公告,FDA不再计划召开评审委员会会议审查该药品。此前该委员会会议被安排在10月9日举行。FDA对这一药品的审批决定日期定于11月28日。\n\n取消专家咨询委员会会议的决定,意味着FDA对govorestat的安全性和有效性持相对乐观态度,提高了该药物获批上市的可能性。一旦获批,govorestat将成为治疗罕见的遗传性代谢疾病半乳糖血症的新药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | FDA取消专家会议引发APLT大涨","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["APLT"],"gpt_icon":0},{"id":"2468300119","title":"BUZZ-美国 FDA 取消遗传性疾病药物专家小组会议,Applied Therapeutics 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2468300119","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468300119?lang=zh_cn&edition=full","pubTime":"2024-09-18 19:55","pubTimestamp":1726660506,"startTime":"0","endTime":"0","summary":"** 美国食品和药物管理局3月份延长了对 ,以审查这种治疗典型半乳糖血症的实验性药物。** 专家小组会议之前暂定于 10 月 9 日举行** 食品及药物管理局先前宣布的对该药物采取行动的日期定于 11 月 28 日** 半乳糖血症是一种罕见的遗传代谢性疾病,患者无法代谢单糖半乳糖。** 截至上一交易日收盘,股价累计上涨约 39","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","BK4139","APLT","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.appliedtherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0289},{"period":"1month","weight":0.0631},{"period":"3month","weight":0.6066},{"period":"6month","weight":1.2721},{"period":"1year","weight":3.8789},{"period":"ytd","weight":1.7672}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Applied Therapeutics, Inc.于2016年1月20日在特拉华州注册成立,总部位于纽约。该公司是一家临床阶段的生物制药公司,开发了一系列新产品候选产品,针对未满足医疗需求的有效分子靶标。该公司的药物开发方法利用最近的技术进步来设计改良药物,利用生物标志物的早期使用来确认生物活性,并侧重于缩短的调节途径。他们的第一个分子靶标是醛糖还原酶,或AR,一种在氧化应激条件下将葡萄糖转化为山梨糖醇的酶,并且涉及多种疾病。他们的AR抑制剂或ARI计划目前包括三个小分子,这些小分子都被设计成有效的选择性ARI,并被设计成具有独特的组织渗透性特征,以针对不同的疾病状态,包括糖尿病并发症,心脏病和罕见的儿科代谢疾病。他们的ARI计划应用策略,他们还开发了一个针对选择性抑制磷脂酰肌醇3-激酶或PI3K亚基的程序,该子单元已导致早期肿瘤学治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.122752},{"month":2,"riseRate":0.4,"avgChangeRate":0.124838},{"month":3,"riseRate":0.2,"avgChangeRate":-0.093856},{"month":4,"riseRate":0.4,"avgChangeRate":0.152129},{"month":5,"riseRate":0.4,"avgChangeRate":-0.046053},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.091706},{"month":7,"riseRate":0.666667,"avgChangeRate":0.074437},{"month":8,"riseRate":0.5,"avgChangeRate":0.019686},{"month":9,"riseRate":0.666667,"avgChangeRate":0.137906},{"month":10,"riseRate":0.333333,"avgChangeRate":0.000959},{"month":11,"riseRate":0.666667,"avgChangeRate":0.10731},{"month":12,"riseRate":0.4,"avgChangeRate":0.110125}],"exchange":"NASDAQ","name":"Applied Therapeutics Inc.","nameEN":"Applied Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Applied Therapeutics Inc.(APLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Applied Therapeutics Inc.(APLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Applied Therapeutics Inc.,APLT,Applied Therapeutics Inc.股票,Applied Therapeutics Inc.股票老虎,Applied Therapeutics Inc.股票老虎国际,Applied Therapeutics Inc.行情,Applied Therapeutics Inc.股票行情,Applied Therapeutics Inc.股价,Applied Therapeutics Inc.股市,Applied Therapeutics Inc.股票价格,Applied Therapeutics Inc.股票交易,Applied Therapeutics Inc.股票购买,Applied Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Applied Therapeutics Inc.(APLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Applied Therapeutics Inc.(APLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}